Company Overview
The Cancer Breakthrough Company Limited is a Dissolved Private Limited Company.
Registered Address

9Th Floor The Royal Liver Building, Pier Head, Liverpool, L3 1JH
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameTHE CANCER BREAKTHROUGH COMPANY LIMITED
Company Number10663906
Registered Office Address9th Floor The Royal Liver Building
 Pier Head
 L3 1JH
Company CategoryPrivate Limited Company
Company StatusDissolved
Country of OriginUnited Kingdom
Incorporation Date10/03/2017
Accounting Reference Date Day31
Accounting Reference Date Month3
Accounts Next Due Date31/12/2022
Accounts Last Made Up Date31/03/2021
Accounts Account CategoryMICRO ENTITY
Returns Next Due Date07/04/2018
Directors & Members
Show Resigned
Brian De Thorpe Millard - Director
(British, 83 years old, born April 1943)
Appointed 10 March 2017
 Active
Secretaries
No Secretaries Appointed
Other Company Directorships
Brian De Thorpe Millard
CANCER INNOVATIONS LIMITED
CHARLEMAGNE CAPITAL HOLDINGS LTD
LIGHT GLOBAL HOLDINGS LIMITED
MONTEREY BAY GROUP LTD.
SDGC GROUP LTD
ZELLEX LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Mar-2021 31-Mar-2020 31-Mar-2019
Balance Sheet
Fixed Assets 0 0 0
Current Assets 100 100 100
Creditors Due Within One Year 0 0 0
Working Cap 100 100 100
Total Assets Less Current Liabilities 100 100 100
Long-term Liabilities 0 0 0
Net Assets 100 100 100
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 100 100 100
Common Size Financial Analysis Unlock full report
Accounts Date 31-Mar-2021 31-Mar-2020 31-Mar-2019
Tangible Fixed Assets - - -
Fixed Assets 0.0% 0.0% 0.0%
Stocks Inventory - - -
Debtors - - -
Cash Bank In Hand - - -
Current Assets 100.0% 100.0% 100.0%
Creditors Due Within One Year 0.0% 0.0% 0.0%
Net Current Assets Liabilities 100.0% 100.0% 100.0%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 100.0% 100.0% 100.0%
Capital Employed - - -
Total Assets Less Current Liabilities 100.0% 100.0% 100.0%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Mar-2021 31-Mar-2020 31-Mar-2019
Liquidity Ratio 100.0 100.0 100.0
Solvency Ratio ∞ ∞ ∞
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Mar-2021 31-Mar-2020 31-Mar-2019
Assets 100 100 100
Debt 0 0 0
Net Assets/Debt 100 100 100
Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around L3 1JH
VACCICURE LIMITED
101 NEW CAVENDISH STREET, 1ST FLOOR SOUTH, LONDON, L3 1JH
CAPSTONE LIFE SCIENCES LLP
101 NEW CAVENDISH STREET, 1ST FLOOR SOUTH, LONDON, L3 1JH
DIATECH ONCOLOGY TPA LIMITED
101 NEW CAVENDISH STREET, 1ST FLOOR SOUTH, LONDON, L3 1JH
PIERIAN BIOSCIENCES LIMITED
101 NEW CAVENDISH STREET, 1ST FLOOR SOUTH, LONDON, L3 1JH
KEYHOLDER FUNDING LIMITED
2nd Floor 14 Castle Street, Liverpool, L3 1JH
BUOOY BIOSCIENCES LIMITED
9th Floor Royal Liver Building, Pier Head, Liverpool, England, L3 1JH
HELOMICS INTERNATIONAL LTD.
9th Floor Royal Liver Building, Pier Head, Liverpool, L3 1JH
CANCER INNOVATIONS LIMITED
The Royal Liver Building, Pier Head, Liverpool, L3 1JH
CELEX ONCOLOGY INNOVATIONS LIMITED
101 NEW CAVENDISH STREET, 1ST FLOOR SOUTH, LONDON, L3 1JH
LONGACRE FUNDING PARTNERS LLP
101 New Cavendish Street, 1st Floor South, London, L3 1JH
Document Filings
Final Gazette dissolved via compulsory strike-off
Termination of appointment of Agamemnon Antoniou Epenetos as a director on 15 July 2022
First Gazette notice for compulsory strike-off
Confirmation statement made on 9 March 2021 with no updates
Confirmation statement made on 9 March 2020 with no updates
Registered office address changed from The Royal Liver Building Pier Head Liverpool L3 1JH England to 9th Floor the Royal Liver Building Pier Head Liverpool L3 1JH on 24 March 2019
Confirmation statement made on 9 March 2019 with no updates
Notification of John Lyndon Hodgson as a person with significant control on 10 March 2017
Notification of Kyra Romano-Scott as a person with significant control on 10 March 2017
Notification of Diane Dentith as a person with significant control on 10 March 2017
Notification of Tracy Jane Pozo as a person with significant control on 10 March 2017
Cessation of Keyholder Investments Limited as a person with significant control on 10 March 2017
Confirmation statement made on 9 March 2018 with no updates
Termination of appointment of Darren Paul Courtney-Cook as a director on 15 June 2017
Appointment of Professor Agamemnon Antoniou Epenetos as a director on 23 March 2017
Appointment of Mr Darren Paul Courtney-Cook as a director on 23 March 2017
Incorporation
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free